Search

Your search keyword '"Sinn, Bruno V."' showing total 81 results
Start Over Author "Sinn, Bruno V." Database Unpaywall
81 results on '"Sinn, Bruno V."'

1. AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication

Author

Monjé, Nanna, primary, Dragomir, Mihnea P., additional, Sinn, Bruno V., additional, Hoffmann, Inga, additional, Makhmut, Anuar, additional, Simon, Tincy, additional, Kunze, Catarina A., additional, Ihlow, Jana, additional, Schmitt, Wolfgang D., additional, Pohl, Jonathan, additional, Piwonski, Iris, additional, Marchenko, Sofya, additional, Keunecke, Carlotta, additional, Calina, Teodor G., additional, Tiso, Francesca, additional, Kulbe, Hagen, additional, Kreuzinger, Caroline, additional, Cacsire Castillo-Tong, Dan, additional, Sehouli, Jalid, additional, Braicu, Elena I., additional, Denkert, Carsten, additional, Darb-Esfahani, Silvia, additional, Kübler, Kirsten, additional, Capper, David, additional, Coscia, Fabian, additional, Morkel, Markus, additional, Horst, David, additional, Sers, Christine, additional, and Taube, Eliane T., additional

Published
2024
Full Text
View/download PDF

2. Supplementary Table 1 from RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial

Author

Link, Theresa, primary, Blohmer, Jens-Uwe, primary, Schmitt, Wolfgang D., primary, Kuhlmann, Jan Dominik, primary, Just, Marianne, primary, Untch, Michael, primary, Stotzer, Oliver, primary, Fasching, Peter A., primary, Thill, Marc, primary, Reinisch, Mattea, primary, Schneeweiss, Andreas, primary, Wimberger, Pauline, primary, Seiler, Sabine, primary, Huober, Jens, primary, Jackisch, Christian, primary, Rhiem, Kerstin, primary, Hanusch, Claus, primary, Sinn, Bruno V., primary, Nekljudova, Valentina, primary, Loibl, Sibylle, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table 1 from RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial

Author

Link, Theresa, primary, Blohmer, Jens-Uwe, primary, Schmitt, Wolfgang D., primary, Kuhlmann, Jan Dominik, primary, Just, Marianne, primary, Untch, Michael, primary, Stotzer, Oliver, primary, Fasching, Peter A., primary, Thill, Marc, primary, Reinisch, Mattea, primary, Schneeweiss, Andreas, primary, Wimberger, Pauline, primary, Seiler, Sabine, primary, Huober, Jens, primary, Jackisch, Christian, primary, Rhiem, Kerstin, primary, Hanusch, Claus, primary, Sinn, Bruno V., primary, Nekljudova, Valentina, primary, Loibl, Sibylle, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

4. Data from RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial

Author

Link, Theresa, primary, Blohmer, Jens-Uwe, primary, Schmitt, Wolfgang D., primary, Kuhlmann, Jan Dominik, primary, Just, Marianne, primary, Untch, Michael, primary, Stotzer, Oliver, primary, Fasching, Peter A., primary, Thill, Marc, primary, Reinisch, Mattea, primary, Schneeweiss, Andreas, primary, Wimberger, Pauline, primary, Seiler, Sabine, primary, Huober, Jens, primary, Jackisch, Christian, primary, Rhiem, Kerstin, primary, Hanusch, Claus, primary, Sinn, Bruno V., primary, Nekljudova, Valentina, primary, Loibl, Sibylle, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

5. Data from RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial

Author

Link, Theresa, primary, Blohmer, Jens-Uwe, primary, Schmitt, Wolfgang D., primary, Kuhlmann, Jan Dominik, primary, Just, Marianne, primary, Untch, Michael, primary, Stotzer, Oliver, primary, Fasching, Peter A., primary, Thill, Marc, primary, Reinisch, Mattea, primary, Schneeweiss, Andreas, primary, Wimberger, Pauline, primary, Seiler, Sabine, primary, Huober, Jens, primary, Jackisch, Christian, primary, Rhiem, Kerstin, primary, Hanusch, Claus, primary, Sinn, Bruno V., primary, Nekljudova, Valentina, primary, Loibl, Sibylle, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

6. Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer

Author

Hoffmann, Inga, primary, Dragomir, Mihnea P., additional, Monjé, Nanna, additional, Keunecke, Carlotta, additional, Kunze, Catarina Alisa, additional, Schallenberg, Simon, additional, Marchenko, Sofya, additional, Schmitt, Wolfgang D., additional, Kulbe, Hagen, additional, Sehouli, Jalid, additional, Braicu, Ioana Elena, additional, Jank, Paul, additional, Denkert, Carsten, additional, Darb-Esfahani, Silvia, additional, Horst, David, additional, Sinn, Bruno V., additional, Sers, Christine, additional, Bischoff, Philip, additional, and Taube, Eliane T., additional

Published
2023
Full Text
View/download PDF

7. RANK expression as an independent predictor for response to neoadjuvant chemotherapy in luminal-like breast cancer - a translational insight from the GeparX trial

Author

Link, Theresa, primary, Blohmer, Jens-Uwe, additional, Schmitt, Wolfgang D., additional, Kuhlmann, Jan Dominik., additional, Just, Marianne, additional, Untch, Michael, additional, Stotzer, Oliver, additional, Fasching, Peter A., additional, Thill, Marc, additional, Reinisch, Mattea, additional, Schneeweiss, Andreas, additional, Wimberger, Pauline, additional, Seiler, Sabine, additional, Huober, Jens, additional, Jackisch, Christian, additional, Rhiem, Kerstin, additional, Hanusch, Claus, additional, Sinn, Bruno V., additional, Nekljudova, Valentina, additional, Loibl, Sibylle, additional, and Denkert, Carsten, additional

Published
2023
Full Text
View/download PDF

8. LRP1B—a prognostic marker in tubo-ovarian high-grade serous carcinoma

Author

Kolb, Svenja, primary, Hoffmann, Inga, additional, Monjé, Nanna, additional, Dragomir, Mihnea P., additional, Jank, Paul, additional, Bischoff, Philip, additional, Keunecke, Carlotta, additional, Pohl, Jonathan, additional, Kunze, Catarina Alisa, additional, Marchenko, Sofya, additional, Schmitt, Wolfgang D., additional, Kulbe, Hagen, additional, Sers, Christine, additional, Sehouli, Jalid, additional, Braicu, Elena Ioana, additional, Denkert, Carsten, additional, Darb-Esfahani, Silvia, additional, Horst, David, additional, Sinn, Bruno V., additional, and Taube, Eliane T., additional

Published
2023
Full Text
View/download PDF

9. Figure S4 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

10. Figure S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure Legend from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

Author

von Minckwitz, Gunter, primary, Schmitt, Wolfgang D., primary, Loibl, Sibylle, primary, Müller, Berit M., primary, Blohmer, Jens U., primary, Sinn, Bruno V., primary, Eidtmann, Holger, primary, Eiermann, Wolfgang, primary, Gerber, Bernd, primary, Tesch, Hans, primary, Hilfrich, Jörn, primary, Huober, Jens, primary, Fehm, Tanja, primary, Barinoff, Jana, primary, Rüdiger, Thomas, primary, Erbstoesser, Erhard, primary, Fasching, Peter A., primary, Karn, Thomas, primary, Müller, Volkmar, primary, Jackisch, Christian, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

12. Figure S5 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

13. Figure S2 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

14. Figure S6 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

15. Figure S3 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

16. Table S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

17. Table S2 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure Legend from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

Author

von Minckwitz, Gunter, primary, Schmitt, Wolfgang D., primary, Loibl, Sibylle, primary, Müller, Berit M., primary, Blohmer, Jens U., primary, Sinn, Bruno V., primary, Eidtmann, Holger, primary, Eiermann, Wolfgang, primary, Gerber, Bernd, primary, Tesch, Hans, primary, Hilfrich, Jörn, primary, Huober, Jens, primary, Fehm, Tanja, primary, Barinoff, Jana, primary, Rüdiger, Thomas, primary, Erbstoesser, Erhard, primary, Fasching, Peter A., primary, Karn, Thomas, primary, Müller, Volkmar, primary, Jackisch, Christian, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

19. Figure S1 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

20. Figure S7 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

21. Figure S5 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

22. Figure S8 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

23. Figure S3 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

24. Figure S2 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

25. Figure S3 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

26. Figure S2 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

27. Figure S8 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

28. Figure S3 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Tables S1-S8 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

30. Figure S6 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

31. Table S2 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

Author

von Minckwitz, Gunter, primary, Schmitt, Wolfgang D., primary, Loibl, Sibylle, primary, Müller, Berit M., primary, Blohmer, Jens U., primary, Sinn, Bruno V., primary, Eidtmann, Holger, primary, Eiermann, Wolfgang, primary, Gerber, Bernd, primary, Tesch, Hans, primary, Hilfrich, Jörn, primary, Huober, Jens, primary, Fehm, Tanja, primary, Barinoff, Jana, primary, Rüdiger, Thomas, primary, Erbstoesser, Erhard, primary, Fasching, Peter A., primary, Karn, Thomas, primary, Müller, Volkmar, primary, Jackisch, Christian, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

Author

von Minckwitz, Gunter, primary, Schmitt, Wolfgang D., primary, Loibl, Sibylle, primary, Müller, Berit M., primary, Blohmer, Jens U., primary, Sinn, Bruno V., primary, Eidtmann, Holger, primary, Eiermann, Wolfgang, primary, Gerber, Bernd, primary, Tesch, Hans, primary, Hilfrich, Jörn, primary, Huober, Jens, primary, Fehm, Tanja, primary, Barinoff, Jana, primary, Rüdiger, Thomas, primary, Erbstoesser, Erhard, primary, Fasching, Peter A., primary, Karn, Thomas, primary, Müller, Volkmar, primary, Jackisch, Christian, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

34. Table S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

35. Figure S2 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

36. Figure S7 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

37. Figure S1 from Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, primary, Hanusch, Claus A., primary, Zahm, Dirk-Michael, primary, Sinn, Hans-Peter, primary, Untch, Michael, primary, Weber, Karsten, primary, Karn, Thomas, primary, Becker, Clemens, primary, Marmé, Frederik, primary, Schmitt, Wolfgang D., primary, Müller, Volkmar, primary, Schem, Christian, primary, Treue, Denise, primary, Stickeler, Elmar, primary, Klauschen, Frederik, primary, Burchardi, Nicole, primary, Furlanetto, Jenny, primary, van Mackelenbergh, Marion, primary, Fasching, Peter A., primary, Schneeweiss, Andreas, primary, and Denkert, Carsten, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Tables S1-S8 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

39. Figure S1 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

40. Figure S4 from A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial

Author

Karn, Thomas, primary, Meissner, Tobias, primary, Weber, Karsten E., primary, Solbach, Christine, primary, Denkert, Carsten, primary, Engels, Knut, primary, Fasching, Peter A., primary, Sinn, Bruno V., primary, Schrader, Iris, primary, Budczies, Jan, primary, Marmé, Frederik, primary, Müller, Volkmar, primary, Holtrich, Uwe, primary, Gerber, Bernd, primary, Schem, Christian, primary, Young, Brandon M., primary, Hanusch, Claus, primary, Stickeler, Elmar, primary, Huober, Jens, primary, van Mackelenbergh, Marion, primary, Leyland-Jones, Brian, primary, Fehm, Tanja, primary, Nekljudova, Valentina, primary, Untch, Michael, primary, and Loibl, Sibylle, primary

Published
2023
Full Text
View/download PDF

41. Abstract PD17-06: Immunohistochemical markers and determinants of clinical response in the Penelope-B trial

Author

Knudsen, Erik S., primary, Rachakonda, Sivaramakrishna, additional, Marmé, Frederik, additional, Martín, Miguel, additional, Untch, Michael, additional, Bonnefoi, Hervé R., additional, Schmitt, Wolfgang D., additional, Kim, Sung-Bae, additional, Bear, Harry D., additional, Witkiewicz, Agnieszka, additional, Im, Seock-Ah, additional, DeMichele, Angela, additional, Van’t Veer, Laura, additional, McCarthy, Nicole, additional, Sinn, Bruno V., additional, Gelmon, Karen, additional, García-Sáenz, José Ángel, additional, Kelly, Catherine M., additional, Reimer, Toralf, additional, Turner, Nicholas, additional, Rojo, Federico, additional, Filipits, Martin, additional, Fasching, Peter A., additional, Schem, Christian, additional, Martin, Lesley-Ann, additional, Liu, Yuan, additional, Toi, Masakazu, additional, Rugo, Hope, additional, Gnant, Michael, additional, Makris, Andreas, additional, Furlanetto, Jenny, additional, Weber, Karsten, additional, Denkert, Carsten, additional, and Loibl, Sibylle, additional

Published
2023
Full Text
View/download PDF

42. Abstract PD4-02: PD4-02 Spatial and temporal heterogeneity of predictive and prognostic signatures in triple-negative breast cancer treated with neoadjuvant combination immune-chemotherapy

Author

Denkert, Carsten, primary, Schneeweiss, Andreas, additional, Rey, Julia, additional, Hattesohl, Akira, additional, Karn, Thomas, additional, Braun, Michael, additional, Jank, Paul, additional, Huober, Jens, additional, Sinn, Hans-Peter, additional, Zahm, Dirk-Michael, additional, Hanusch, Claus, additional, Marmé, Frederik, additional, Furlanetto, Jenny, additional, Thomalla, Jörg, additional, Blohmer, Jens-Uwe, additional, van Mackelenbergh, Marion, additional, Stiewe, Thorsten, additional, Staib, Peter, additional, Jackisch, Christian, additional, Teply-Szymanski, Julia, additional, Fasching, Peter A., additional, Sinn, Bruno V., additional, Untch, Michael, additional, Weber, Karsten, additional, and Loibl, Sibylle, additional

Published
2023
Full Text
View/download PDF

44. Correction to “Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling”

Author

Brockmöller, Scarlet F., primary, Bucher, Elmar, additional, Müller, Berit M., additional, Budczies, Jan, additional, Hilvo, Mika, additional, Griffin, Julian L., additional, Orešič, Matej, additional, Kallioniemi, Olli, additional, Iljin, Kristiina, additional, Loibl, Sibylle, additional, Darb-Esfahani, Silvia, additional, Sinn, Bruno V., additional, Klauschen, Frederick, additional, Prinzler, Judith, additional, Bangemann, Nikola, additional, Ismaeel, Fakher, additional, Fiehn, Oliver, additional, Dietel, Manfred, additional, and Denkert, Carsten, additional

Published
2022
Full Text
View/download PDF

45. Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

Author

Blenman, Kim R.M., primary, Marczyk, Michal, additional, Karn, Thomas, additional, Qing, Tao, additional, Li, Xiaotong, additional, Gunasekharan, Vignesh, additional, Yaghoobi, Vesal, additional, Bai, Yalai, additional, Ibrahim, Eiman Y., additional, Park, Tristen, additional, Silber, Andrea, additional, Wolf, Denise M., additional, Reisenbichler, Emily, additional, Denkert, Carsten, additional, Sinn, Bruno V., additional, Rozenblit, Mariya, additional, Foldi, Julia, additional, Rimm, David L., additional, Loibl, Sibylle, additional, and Pusztai, Lajos, additional

Published
2022
Full Text
View/download PDF

46. DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

Author

Jurmeister, Philipp, primary, Weber, Karsten, additional, Villegas, Sonia, additional, Karn, Thomas, additional, Untch, Michael, additional, Thieme, Anne, additional, Müller, Volkmar, additional, Taube, Eliane, additional, Fasching, Peter, additional, Schmitt, Wolfgang D., additional, Marmé, Frederik, additional, Stickeler, Elmar, additional, Sinn, Bruno V., additional, Jank, Paul, additional, Schem, Christian, additional, Klauschen, Frederick, additional, van Mackelenbergh, Marion, additional, Denkert, Carsten, additional, Loibl, Sibylle, additional, and Capper, David, additional

Published
2021
Full Text
View/download PDF

47. Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)

Author

Möbus, Volker, primary, Lück, Hans-Joachim, additional, Ladda, Ekkehart, additional, Klare, Peter, additional, Schmidt, Marcus, additional, Schneeweiss, Andreas, additional, Grischke, Eva-Maria, additional, Wachsmann, Grischa, additional, Forstbauer, Helmut, additional, Untch, Michael, additional, Marmé, Frederik, additional, Blohmer, Jens-Uwe, additional, Jackisch, Christian, additional, Huober, Jens, additional, Stickeler, Elmar, additional, Reinisch, Mattea, additional, Link, Theresa, additional, Sinn, Bruno V., additional, Janni, Wolfgang, additional, Denkert, Carsten, additional, Furlanetto, Jenny, additional, Engels, Knut, additional, Solbach, Christine, additional, Schmatloch, Sabine, additional, Rey, Julia, additional, Burchardi, Nicole, additional, and Loibl, Sibylle, additional

Published
2021
Full Text
View/download PDF

48. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

Author

Denkert, Carsten, primary, Seither, Fenja, additional, Schneeweiss, Andreas, additional, Link, Theresa, additional, Blohmer, Jens-Uwe, additional, Just, Marianne, additional, Wimberger, Pauline, additional, Forberger, Almuth, additional, Tesch, Hans, additional, Jackisch, Christian, additional, Schmatloch, Sabine, additional, Reinisch, Mattea, additional, Solomayer, Erich F, additional, Schmitt, Wolfgang D, additional, Hanusch, Claus, additional, Fasching, Peter A, additional, Lübbe, Kristina, additional, Solbach, Christine, additional, Huober, Jens, additional, Rhiem, Kerstin, additional, Marmé, Frederik, additional, Reimer, Toralf, additional, Schmidt, Marcus, additional, Sinn, Bruno V, additional, Janni, Wolfgang, additional, Stickeler, Elmar, additional, Michel, Laura, additional, Stötzer, Oliver, additional, Hahnen, Eric, additional, Furlanetto, Jenny, additional, Seiler, Sabine, additional, Nekljudova, Valentina, additional, Untch, Michael, additional, and Loibl, Sibylle, additional

Published
2021
Full Text
View/download PDF

49. Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials

Author

Villegas, Sonia L., primary, Nekljudova, Valentina, additional, Pfarr, Nicole, additional, Engel, Jutta, additional, Untch, Michael, additional, Schrodi, Simone, additional, Holms, Frank, additional, Ulmer, Hans U., additional, Fasching, Peter A., additional, Weber, Karsten E., additional, Albig, Christian, additional, Heinrichs, Clemens, additional, Marmé, Frederik, additional, Hartmann, Arndt, additional, Hanusch, Claus, additional, Schmitt, Wolfgang D., additional, Huober, Jens, additional, Lederer, Bianca, additional, van Mackelenbergh, Marion, additional, Tesch, Hans, additional, Jackisch, Christian, additional, Rezai, Mahdi, additional, Sinn, Peter, additional, Sinn, Bruno V., additional, Hackmann, John, additional, Kiechle, Marion, additional, Schneeweiss, Andreas, additional, Weichert, Wilko, additional, Denkert, Carsten, additional, and Loibl, Sibylle, additional

Published
2021
Full Text
View/download PDF

50. Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

Author

Sinn, Bruno V., primary, Loibl, Sibylle, additional, Hanusch, Claus A., additional, Zahm, Dirk-Michael, additional, Sinn, Hans-Peter, additional, Untch, Michael, additional, Weber, Karsten, additional, Karn, Thomas, additional, Becker, Clemens, additional, Marmé, Frederik, additional, Schmitt, Wolfgang D., additional, Müller, Volkmar, additional, Schem, Christian, additional, Treue, Denise, additional, Stickeler, Elmar, additional, Klauschen, Frederik, additional, Burchardi, Nicole, additional, Furlanetto, Jenny, additional, van Mackelenbergh, Marion, additional, Fasching, Peter A., additional, Schneeweiss, Andreas, additional, and Denkert, Carsten, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results